Dynamiceuticals: The Next Stage in Personalized Medicine

Area of Science:

• Pharmacology and Biomedical Engineering
• Personalized Medicine and Computational Biology

Background:

• Growing interest in personalized medicine necessitates advanced therapeutic strategies.
• Current trial-and-error or open-loop approaches have limitations in efficacy and side effect management.
• Dynamiceuticals emerges as a novel approach extending pharmaceutical and electroceutical fields.

Purpose of the Study:

• To explore the potential of Dynamiceuticals for implementing individualized therapies.
• To assess if current knowledge and technology support the claims of Dynamiceuticals.
• To evaluate the feasibility of precisely tailoring therapies based on dynamic pathophysiological regimes.

Main Methods:

• Conceptual framework development for Dynamiceuticals.
• Analysis of the integration of pharmaceutical and electroceutical principles.
• Review of current technological and knowledge-based capabilities.

Main Results:

• Dynamiceuticals proposes a method for precise determination of pathophysiological dynamical regimes.
• This precise determination can guide the development of well-controlled, individualized therapies.
• Potential for reduced side effects and superior efficacy compared to existing strategies.

Conclusions:

• Dynamiceuticals presents a promising, rational approach for individualized medicine.
• Further advancements in knowledge and technology are crucial for its full realization.
• The proposed method offers a potential paradigm shift from current therapeutic strategies.